The journal retracts the September 27, 2021 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns about the validity of the data, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.
This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers.
The authors agree with this retraction.
Summary
Keywords
gastric cancer, OTUB2, KDM1A, cancer stem cells, OTUB2/KDM1A
Citation
Frontiers Editorial Office (2023) Retraction: OTUB2 facilitates tumorigenesis of gastric cancer through promoting KDM1A-mediated stem cell-like properties. Front. Oncol. 13:1209867. doi: 10.3389/fonc.2023.1209867
Received
21 April 2023
Accepted
27 April 2023
Published
23 May 2023
Approved by
Liang Qiao, Westmead Institute for Medical Research, Australia
Volume
13 - 2023
Updates
Copyright
© 2023 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.